Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility

Tommy E. White, Alberto Brandariz-Nuñez, Jose Carlos Valle-Casuso, Caitlin Knowlton, Baek Kim, Sara L. Sawyer, Felipe Diaz-Griffero

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


SAMHD1 is a human restriction factor that prevents efficient infection of macrophages, dendritic cells and resting CD4+ T cells by HIV-1. Here we explored the antiviral activity and biochemical properties of human SAMHD1 polymorphisms. Our studies focused on human SAMHD1 polymorphisms that were previously identified as evolving under positive selection for rapid amino acid replacement during primate speciation. The different human SAMHD1 polymorphisms were tested for their ability to block HIV-1, HIV-2 and equine infectious anemia virus (EIAV). All studied SAMHD1 variants block HIV-1, HIV-2 and EIAV infection when compared to wild type. We found that these variants did not lose their ability to oligomerize or to bind RNA. Furthermore, all tested variants were susceptible to degradation by Vpx, and localized to the nuclear compartment. We tested the ability of human SAMHD1 polymorphisms to decrease the dNTP cellular levels. In agreement, none of the different SAMHD1 variants lost their ability to reduce cellular levels of dNTPs. Finally, we found that none of the tested human SAMHD1 polymorphisms affected the ability of the protein to block LINE-1 retrotransposition.

Original languageEnglish (US)
Pages (from-to)34-44
Number of pages11
Issue number1
StatePublished - Jul 2014


  • DNTPs
  • HIV-1
  • LINE-1
  • SAMHD1
  • SNPs
  • Vpx

ASJC Scopus subject areas

  • Virology


Dive into the research topics of 'Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility'. Together they form a unique fingerprint.

Cite this